THE COST-EFFECTIVENESS OF DENOSUMAB FOR THE PREVENTION OF OSTEOPOROTIC FRACTURES IN THE SETTING OF THE UNITED STATES

被引：3
|
作者：
Jiang, Y. [1 ]
Hay, J. [2 ]
机构：
[1] USC Sch Pharm, Los Angeles, CA USA
[2] Univ So Calif, Los Angeles, CA USA
来源：
VALUE IN HEALTH | 2012年 / 15卷 / 04期
关键词：
D O I：
10.1016/j.jval.2012.03.216
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A38 / A38
页数：1
相关论文
共 50 条
  • [1] Cost-effectiveness of raloxifene for the prevention of osteoporotic fractures in Australia
    Davey, PJ
    Lees, M
    Graham-Clarke, P
    [J]. VALUE IN HEALTH, 2003, 6 (03) : 224 - 224
  • [2] Cost-effectiveness of alendronate in the prevention of osteoporotic fractures in Danish women
    Christensen, PM
    Brixen, K
    Gyrd-Hansen, D
    Kristiansen, IS
    [J]. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2005, 96 (05) : 387 - 396
  • [3] COST-EFFECTIVENESS ANALYSIS OF ENHANCING ADHERENCE TO BISPHOSPHONATES THERAPY IN THE SETTING OF PRIMARY PREVENTION OF OSTEOPOROTIC FRACTURES
    Scotti, L.
    Zambon, A.
    Arfe, A.
    Ghirardi, A.
    Nicotra, F.
    Baio, G.
    Corrao, G.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2011, 22 : S743 - S743
  • [4] COST-EFFECTIVENESS OF DENOSUMAB IN PREVENTING OSTEOPOROTIC FRACTURES IN POSTMENOPAUSAL WOMEN FROM THE PRIVATE HEALTH CARE SETTING PERSPECTIVE IN BRAZIL
    Barbosa, E. G.
    Machado, M.
    Araujo, G. T. B. D.
    Etto, H.
    Fonseca, M.
    Olimpio, A.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A446 - A447
  • [5] Cost-effectiveness of denosumab in the treatment of postmenopausal osteoporotic women
    Hiligsmann, Mickael
    Boonen, Annelies
    Dirksen, Carmen D.
    Ben Sedrine, Wafa
    Reginster, Jean-Yves
    [J]. EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2013, 13 (01) : 19 - 28
  • [6] COST-EFFECTIVENESS OF PRIMARY PREVENTION FOR OSTEOPOROTIC HIP FRACTURES IN ELDERLY WOMEN
    Comas, M.
    Posso, M.
    Louro, J.
    Espallargues, M.
    Tebe, C.
    Domingo, L.
    Castells, X.
    [J]. VALUE IN HEALTH, 2018, 21 : S295 - S295
  • [7] Cost-effectiveness of teriparatide in the prevention of osteoporotic fractures in Australian men and women
    Lees, M
    Graham-Clarke, P
    Davey, P
    Thiebaud, D
    Price, N
    Grainger, D
    [J]. OSTEOPOROSIS INTERNATIONAL, 2003, 14 : S12 - S13
  • [8] COST-EFFECTIVENESS ANALYSIS OF ALENDRONATE THERAPY FOR SECONDARY PREVENTION OF OSTEOPOROTIC FRACTURES
    Moriwaki, K.
    Komaba, H.
    Noto, S.
    Yanagisawa, S.
    Takiguchi, T.
    Toujo, T.
    Inoue, H.
    Fukagawa, M.
    Takahashi, H. E.
    [J]. VALUE IN HEALTH, 2013, 16 (07) : A571 - A571
  • [9] Potential cost-effectiveness of denosumab for the treatment of postmenopausal osteoporotic women
    Hiligsmann, Mickael
    Reginster, Jean-Yves
    [J]. BONE, 2010, 47 (01) : 34 - 40
  • [10] COST-EFFECTIVENESS OF DAIRY PRODUCTS SUPPLEMENTED WITH VITAMIN D IN THE PREVENTION OF OSTEOPOROTIC FRACTURES
    Ethgen, O.
    Hiligsmann, M.
    Bruyere, O.
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2015, 26 : S372 - S373
12345